Evonik Donates Funds To  Parsippany Volunteer Ambulance Squad  

Grant From Global Innovation Leader Marks Company's New Corporate Identity 

PARSIPPANY, N.J., December 4, 2007 –  Evonik Industries, whose chemical operations were formerly known as Degussa, today presented the Parsippany Volunteer Ambulance Squad with a $500 community grant to support the Squad’s far-reaching volunteer efforts.  

John Rolando, president of Evonik Degussa Corporation, said the company made the donation to introduce its new identity to the community.  

“Our donation is Evonik’s company-wide commitment to the communities where we live and work,” said Rolando. “Without chemistry, many of the

Chris Miller, Vice President of the Parsippany Volunteer Ambulance Squad, said the Squad – which does not bill the individuals it helps for any services – was extremely appreciative of Evonik Degussa’s donation.  

“Since we are an all volunteer organization, any money we receive is put to good use to maintain our equipment or to purchase supplies,” said Miller. “We are especially thankful to Evonik Degussa and wish other companies in the area were as generous.  

He added that earlier this year, Evonik Degussa Corporation donated $1,500 to the Parsippany Volunteer Ambulance Squad to help fund the purchase of a new stretcher. “The Squad is on call 24 hours a day, seven days a week so it’s important for us to have the best equipment and adequate supplies,” Miller said.

Company information

Evonik Industries AG is the creative industrial group which operates in three highly profitable, promising business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability.  

Evonik Industries is active in over 100 countries around the world. In fiscal 2006 around 43,000 employees generated sales of €14.8 billion and operating profit (EBIT) of over €1.2 billion. Evonik plans to enter the capital market in the first half of 2008.  

Disclaimer

In so far as forecasts or expectations are expressed in this press release and where our forward-looking statements concern the future, these forecasts, expectations and statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Evonik Industries AG assumes no obligation to update the forecasts, expectations or statements contained in this release.  

For more information, contact:

Mike Sheridan

Evonik Degussa Corporation

Tel: 973-541-8812

E-mail: mike.sheridan@degussa.Mike Sheridan
Evonik Degussa Corporatin
Tel:  973-541-8812
E-mail:  mike.sheridan@degussa.com